Table 2.
Association with bleeding.
| Variable | Multivariable model | p |
|---|---|---|
| aOR (95% CI) | ||
| Mechanical ventilation | 2.53 (1.04–6.16) | 0.042 |
| Resuscitation prior to PCI | 1.01 (0.42–2.44) | 0.97 |
| Male sex | 0.90 (0.43–1.90) | 0.78 |
| Radial access | 1.28 (0.47–3.51) | 0.63 |
| P2Y12a | 0.003 | |
| Ticagrelor | 0.40 (0.18–0.92) | 0.032 |
| Prasugrel | 0.20 (0.05–0.85) | 0.029 |
| P2Y12 combination | 2.31 (0.71–7.48) | 0.16 |
| GPI | 1.002 (0.481–2.089) | 0.99 |
| Bivalirudin | 2.34 (0.83–6.60) | 0.11 |
| Oral AC therapy | 0.53 (0.14–2.09) | 0.37 |
| Anemia on admission | 3.44 (1.55–7.67) | 0.002 |
| Age, years | 0.96 (0.93–0.99) | 0.015 |
| GFR (ml/min/1.73 m2) | 0.98 (0.96–0.99) | 0.003 |
| Renal replacement therapy | 1.21 (0.30–4.94) | 0.80 |
AC, anticoagulant therapy; aOR, adjusted odd ratio; CI, confidence interval; GFR, glomerular filtration rate; GPI, GP IIb/IIIa receptor antagonist; P2Y12, P2Y12 receptor antagonist.
a
Clopidogrel group as reference.